First-ever guideline issued for cardiovascular-kidney-metabolic syndrome
The American Heart Association, American College of Cardiology, and two partner organizations have released the first-ever clinical practice guideline for cardiovascular-kidney-metabolic (CKM) syndrome, a framework linking obesity, Type 2 diabetes, chronic kidney disease, and cardiovascular disease. The guideline introduces a four-stage classification system, recommends earlier and broader screening, and endorses treatments including GLP-1-based therapies and SGLT2 inhibitors. It matters because nearly 90% of U.S. adults have at least one CKM risk factor, and the unified framework aims to prevent serious cardiac events through coordinated, earlier intervention.
Published simultaneously in Circulation and JACC on June 9, 2026, the first-ever CKM syndrome guideline was developed jointly by the American Heart Association, American College of Cardiology, American Diabetes Association, and American Society of Nephrology. The guideline establishes a four-stage classification ranging from overweight or prediabetes without other complications (Stage 1) to diagnosed cardiovascular disease alongside metabolic or kidney conditions (Stage 4), allowing clinicians to tailor prevention and treatment strategies to individual risk levels. A key emphasis is earlier screening, particularly for obesity — measured by both BMI and waist circumference — beginning at age 6, while the guideline also calls for screening social determinants of health such as food insecurity and housing instability. For the first time, GLP-1-based therapies are formally recommended for select individuals with obesity and/or Type 2 diabetes who have additional cardiovascular risk factors, alongside SGLT2 inhibitors and, where appropriate, metabolic and bariatric surgery. The guideline also introduces the PREVENT equations, which incorporate kidney and metabolic health factors to provide more precise 10- and 30-year cardiovascular risk estimates than previous tools. Writing committee chair Dr. Chiadi Ndumele of Johns Hopkins emphasized that heart, kidney, and metabolic conditions are deeply interconnected and that coordinated, interdisciplinary care focused on prevention is essential to reducing the burden of cardiovascular disease before major events occur. Lifestyle modifications aligned with the AHA's Life's Essential 8 — covering physical activity, diet, weight, blood pressure, blood sugar, cholesterol, tobacco avoidance, and sleep — are central to the guideline's recommendations.
What's missing
The guideline does not appear to address implementation challenges such as healthcare system capacity to deliver coordinated interdisciplinary CKM care, or potential cost or insurance coverage barriers for recommended therapies like GLP-1 agonists.
How coverage differed
The Independent framed the guideline primarily through the lens of obesity screening and the scale of population risk ("9 in 10 Americans"), emphasizing the public health urgency and individual lifestyle factors. Mirage News and Medical Xpress presented the story in a more clinical and institutional register, foregrounding the guideline's staging system, treatment recommendations, and multi-organization authorship without the same emphasis on the obesity angle.
What different sources said
- Mirage NewsCenter
New Guidelines Issued for Cardio-Kidney-Metabolic Syndrome
- Medical XpressCenter
First-ever guideline on cardiovascular-kidney-metabolic syndrome issued
- The IndependentLeft
FDA issues new kidney warning for weight loss pill
- professional.heart.orgCenter
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
- Times of IndiaCenter
Kidney disease: New drug shows tremendous promise; offers hope beyond diabetes
Related
Chicago Woman's Five-Year Symptom Journey Leads to Rare Brain Tumor Diagnosis
Melony Aponte, 26, was diagnosed with a 4.5-centimeter acoustic neuroma after five years of symptoms she attributed to stress, COVID-19, and aging. The rare, noncancerous tumor—affecting roughly one in 100,000 people—had grown large enough to compress her hearing and balance nerve before it was identified via MRI in March 2025. Her case highlights how acoustic neuroma symptoms can mimic common conditions, potentially delaying diagnosis for years.
Study Finds Aging Shifts Walking Strategy Toward Stability at the Cost of Efficiency
A new study from Flinders University and the University of Canberra found that as people age, their bodies adopt a 'safety-first' walking pattern that prioritizes balance over efficient movement. Researchers analyzed gait data from 107 healthy adults aged 26 to 86, identifying increased ankle muscle co-contraction and reduced push-off power as key age-related changes. The findings suggest that fall prevention programs should target balance and coordination, not just muscle strength.
Tick Populations Surge in Urban Areas Across Northeast
Experts across the northeastern United States and Canada are warning of an unusually early and widespread tick season, with disease-carrying ticks increasingly found in urban parks and green spaces. Lyme disease cases in Canada reached a record 7,105 in 2025, up from 5,809 the previous year, while U.S. cities including Philadelphia, Pittsburgh, Washington D.C., and New York are reporting rising tick activity. The expansion poses a public health challenge because urban residents are less likely to take tick-bite precautions than those in rural areas.